We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Simple Blood Test Identifies Metabolic Signature of Healthier Aging

By LabMedica International staff writers
Posted on 03 Oct 2025

Exercise has long been known to protect mobility and reduce the risk of chronic disease, but the molecular processes that translate activity into healthier aging have remained unclear. More...

Researchers have studied whether the benefits of an active lifestyle could be seen directly in blood and whether specific molecules could serve as markers of fitness. Now, a new study shows that a simple blood test, combined with advanced analytics, can track how well someone is aging and identify key metabolites linked to physical performance.

A research team from the University of Vienna (Vienna, Austria), in collaboration with Nankai University (Tianjin, China), has developed a method that merges metabolomics with machine learning and a novel modeling tool. They first created a Body Activity Index (BAI) from physical tests and a Metabolomics Index from blood concentrations of 35 metabolites. The approach captures both endurance and molecular signals, providing a comprehensive measure of active aging at the systemic level.

The study analyzed 263 samples from older adults and found a strong correlation between the two indices, with a Pearson coefficient of 0.85. Five machine-learning models were trained to classify active versus less-active groups, with boosting methods achieving over 91% accuracy (AUC > 0.91). Across all models, eight metabolites consistently predicted activity, with aspartate emerging as the dominant biomarker of physical fitness.

To explore how these molecules interact, the team applied COVRECON, a network modeling tool that reconstructs biochemical connections. The analysis identified aspartate aminotransferase (AST) and alanine aminotransferase (ALT) as central hubs in metabolic rewiring, validated through standard blood tests. Active participants showed greater fluctuations in AST and ALT over six months, suggesting enhanced metabolic flexibility in liver and muscle function.

The findings, published in npj Systems Biology and Applications, also connect fitness to brain health, as aspartate plays a dual role as a neurotransmitter precursor, influencing learning and memory. Low AST and ALT levels or elevated ratios have been linked to a higher risk of Alzheimer’s disease and cognitive decline. By linking activity-driven metabolic shifts to brain resilience, the study suggests that blood-based biomarkers could one day track both physical and cognitive aging.

“Physical activity does more than building up muscle mass. It rewires our metabolism at the molecular level. By decoding those changes, we can track – and even guide—how well someone is aging,” said Wolfram Weckwerth, professor at the University of Vienna.

Related Links:
University of Vienna
Nankai University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gastrointestinal Panel
Xpert® GI Panel
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.